Progenics Pharmaceuticals, Inc. Announces Pricing Of Public Offering Of Common Stock

Progenics Pharmaceuticals Announces Pricing of Public Offering of Common Stock TARRYTOWN, N.Y., Feb. 21, 2014 -- Progenics Pharmaceuticals, Inc. announced today the pricing of an underwritten public offering of 7,608,696 primary shares of its common stock at a public offering price of $4.60 per share.

http://ift.tt/1p1zCCf